SE0202022D0 - Synergistic interaction of abacavir and alovudine - Google Patents

Synergistic interaction of abacavir and alovudine

Info

Publication number
SE0202022D0
SE0202022D0 SE0202022A SE0202022A SE0202022D0 SE 0202022 D0 SE0202022 D0 SE 0202022D0 SE 0202022 A SE0202022 A SE 0202022A SE 0202022 A SE0202022 A SE 0202022A SE 0202022 D0 SE0202022 D0 SE 0202022D0
Authority
SE
Sweden
Prior art keywords
alovudine
abacavir
synergistic interaction
synergistic
interaction
Prior art date
Application number
SE0202022A
Other languages
Swedish (sv)
Inventor
Goeran Maardh
Original Assignee
Medivir Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medivir Ab filed Critical Medivir Ab
Priority to SE0202022A priority Critical patent/SE0202022D0/en
Publication of SE0202022D0 publication Critical patent/SE0202022D0/en
Priority to CNB038151685A priority patent/CN1302779C/en
Priority to EP03733801A priority patent/EP1536800B1/en
Priority to US10/519,332 priority patent/US20060084627A1/en
Priority to RU2005101874/15A priority patent/RU2320347C2/en
Priority to CA002481890A priority patent/CA2481890A1/en
Priority to MXPA04012754A priority patent/MXPA04012754A/en
Priority to ES03733801T priority patent/ES2254941T3/en
Priority to AT03733801T priority patent/ATE314851T1/en
Priority to AU2003239088A priority patent/AU2003239088B2/en
Priority to KR10-2004-7021155A priority patent/KR20050013628A/en
Priority to PCT/SE2003/001100 priority patent/WO2004002433A1/en
Priority to PL03373758A priority patent/PL373758A1/en
Priority to BR0311141-5A priority patent/BR0311141A/en
Priority to NZ535817A priority patent/NZ535817A/en
Priority to DE60303131T priority patent/DE60303131T2/en
Priority to JP2004548906A priority patent/JP2005533870A/en
Priority to ZA200408599A priority patent/ZA200408599B/en
Priority to IL16492104A priority patent/IL164921A0/en
Priority to NO20050445A priority patent/NO20050445L/en
Priority to HK06100011.9A priority patent/HK1079981B/en

Links

SE0202022A 2002-06-27 2002-06-27 Synergistic interaction of abacavir and alovudine SE0202022D0 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
SE0202022A SE0202022D0 (en) 2002-06-27 2002-06-27 Synergistic interaction of abacavir and alovudine
JP2004548906A JP2005533870A (en) 2002-06-27 2003-06-24 Synergistic interaction of abaca beer and alovudine
AT03733801T ATE314851T1 (en) 2002-06-27 2003-06-24 SYNERGISTIC INTERACTION OF ABACAVIR AND ALOVUDINE
KR10-2004-7021155A KR20050013628A (en) 2002-06-27 2003-06-24 Synergistic interaction of abacavir and alovudine
US10/519,332 US20060084627A1 (en) 2002-06-27 2003-06-24 Synergistic interaction of abacavir and alovudine
RU2005101874/15A RU2320347C2 (en) 2002-06-27 2003-06-24 Synergistic interaction of abacavir and alovudin
CA002481890A CA2481890A1 (en) 2002-06-27 2003-06-24 Synergistic interaction of abacavir and alovudine
MXPA04012754A MXPA04012754A (en) 2002-06-27 2003-06-24 Synergistic interaction of abacavir and alovudine.
ES03733801T ES2254941T3 (en) 2002-06-27 2003-06-24 SYNERGIC INTERACTION BETWEEN ABACAVIR AND ALOVUDINA.
CNB038151685A CN1302779C (en) 2002-06-27 2003-06-24 Synergistic interaction of abacavir and alovudine
AU2003239088A AU2003239088B2 (en) 2002-06-27 2003-06-24 Synergistic interaction of abacavir and alovudine
EP03733801A EP1536800B1 (en) 2002-06-27 2003-06-24 Synergistic interaction of abacavir and alovudine
PCT/SE2003/001100 WO2004002433A1 (en) 2002-06-27 2003-06-24 Synergistic interaction of abacavir and alovudine
PL03373758A PL373758A1 (en) 2002-06-27 2003-06-24 Synergistic interaction of abacavir and alovudine
BR0311141-5A BR0311141A (en) 2002-06-27 2003-06-24 Synergistically interaction of abacavir and alovudine
NZ535817A NZ535817A (en) 2002-06-27 2003-06-24 Synergistic interaction of abacavir and alovudine
DE60303131T DE60303131T2 (en) 2002-06-27 2003-06-24 SYNERGISTIC INTERACTION OF ABACAVIR AND ALOVUDIN
ZA200408599A ZA200408599B (en) 2002-06-27 2004-10-22 Synergistic interaction of abacavir and alovudine.
IL16492104A IL164921A0 (en) 2002-06-27 2004-10-28 Synergistic interaction of abacavir and alovudine
NO20050445A NO20050445L (en) 2002-06-27 2005-01-26 Synergistic interaction between abacavir and alovudine
HK06100011.9A HK1079981B (en) 2002-06-27 2006-01-03 A pharmaceutical preparation comprising a abacavir and alovudine and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0202022A SE0202022D0 (en) 2002-06-27 2002-06-27 Synergistic interaction of abacavir and alovudine

Publications (1)

Publication Number Publication Date
SE0202022D0 true SE0202022D0 (en) 2002-06-27

Family

ID=20288372

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0202022A SE0202022D0 (en) 2002-06-27 2002-06-27 Synergistic interaction of abacavir and alovudine

Country Status (2)

Country Link
SE (1) SE0202022D0 (en)
ZA (1) ZA200408599B (en)

Also Published As

Publication number Publication date
ZA200408599B (en) 2005-08-31

Similar Documents

Publication Publication Date Title
PL372814A1 (en) Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
EP1827391A4 (en) Dosage forms and methods of use thereof
DE50210454D1 (en) Parking and / or Rangierhilfeeinrichtung
EE05516B1 (en) Indazoles Benzothiazoles and Benzoisothiazoles Their Preparation and Use
IS7689A (en) Multiple component dosage forms
DE60317699D1 (en) FERMENTATION PROCESSES AND COMPOSITIONS
NO20052278L (en) Piperazinyl and diazapanyl benzamides and benzthioamides
AU2003298514A8 (en) Methods and compositions using cholinesterase inhibitors
AU2003259735A8 (en) Small-mer compositions and methods of use
EP1838291A4 (en) Pharmaceutical formulations and methods of use
IL183689A (en) Pharmaceutical compositions for improving the structure and function of arterioles
DE60319951D1 (en) AMINOCYCLIC SUBSTITUTED PYRROLOPYRIMIDIN DERIVATIVES AND PYRROLOPYRIDINE DERIVATIVES
AU2003299441A8 (en) Nf-hev compositions and methods of use
ATE512148T1 (en) PYRAZOLO AND IMIDAZOPYRIMIDE DERIVATIVES
EP1766092A4 (en) Target-specific compomers and methods of use
PL374581A1 (en) Diaminothiazoles and use thereof as cdk4 inhibitors
DE60318139D1 (en) Isolator and arrangement configuration
FI20041220A0 (en) New lacquer enzyme and its use
IS8326A (en) The mixture of serotonin reuptake inhibitor and loxapine
SE0202022D0 (en) Synergistic interaction of abacavir and alovudine
FI20031458A (en) Carrying case and carrying structure
DE50313181D1 (en) ALKYL AND / OR ALKYLENOLIGOGLYCOSIDE BETAINESTERQUATS
DE60110606D1 (en) 16ALPHA-METHYL OR ETHYL SUBSTITUTED OESTROGENE
IL177751A0 (en) Pharmaceutical composition of (+)-erythro-mefloquine and its use
UA9216S (en) SET OF PATERLITZ AND CROSS